News
Published over 15 years ago. See the latest and most current information on News.
Molecular Profiles has expanded manufacturing capabilities on its existing site in Nottingham enabling the company to handle larger projects for pharmaceutical clients from pre-formulation through to Phase IIa: the service will initially focusing on difficult-to-formulate molecules, increasing the range of services available to its customers.
Nikin Patel, PhD MRPharmS, CEO of Molecular Profiles, commented: "What makes Molecular Profiles unique is that we have an innovative problem-to-solution approach, which has resolved some of the toughest drug substance and formulation issues. We have a large number of highly experienced PhDs with a track record including over 1000 projects and many blockbuster products.
This, coupled with our dedication to providing the best service for our customers, means we provide a consummate and cost-effective project delivery."
Nikin continued: "The Informex exhibition will enable us to highlight our new ability to provide a comprehensive value-added pharmaceutical development service. Our company has the expertise to work on difficult-to-handle molecules and in particular, poorly water soluble drugs and highly potents. The expansion of our service offering greatly reduces the need for technical transfer and ensures products get developed in time."
ILM Guide 2026/27